Development of abnormalities at the neuromuscular junction in the SOD1-G93A mouse model of ALS: dysfunction then disruption of postsynaptic structure precede overt motor symptoms
McIntosh, J., Mekrouda, I., Dashti, M., Giuraniuc, C. V., Banks, R. W., Miles, G. B., Bewick, G. S.
Frontiers in Molecular Neuroscience, vol. 16, 1169075
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, Cooper, J., Soiza, R., Bateman, V., Black, M., Brittain-Long, R., Collie, K., Counter, D., Coutts, A., Devkota, S., Dospinescu, P., Flett, F., Ganley, P., Hunter, R., Irvine, J., Kane, L., Kaye, C., Khan, A., Laing, R., MacKenzie, A., Macleod, M., McLay, J., Noble, J., Norris, K., Taylor, V., Tonna, I., Vileito, A., Walker, L., Hornby, P. W., Landray, M. J.
Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507